4-Demethylpenclomedine

N/A

Report date: 2022/03/23 14:31:02
NME

Base Information

Drug Name4-Demethylpenclomedine
Drug Alias NameClomet4-DM-PENDMPEN
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA synthesis inhibitorsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins UniversitySouthern Research InstituteUs Department Of Health & Human Services
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSouthern Research InstituteAntisomaUs Department Of Health & Human Services +[4] 
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A